← Back to headlines
Immunic CEO Discusses Q2 Progress and Phase 3 MS Trial Milestones
The CEO of Immunic provided an update on the company's progress in the second quarter and highlighted key milestones achieved in its Phase 3 multiple sclerosis trial.
10 Aug, 19:07 — 10 Aug, 19:07
Sources
Showing 1 of 1 sources
Related Stories
Nigerian Government and Student Union Criticize Atiku’s Push to Restore Fuel Subsidies
19m ago
Meta Agrees to $18 Billion Settlement in Child Social Media Addiction Lawsuits
25m ago
Romanian President Sends Decarbonization Law to Constitutional Court
27m ago
Italy Revives One-Euro Home Sales Program Amid Housing Initiatives
33m ago